EQRx is a startup based in the United States, most recent round Acquired, 2 tracked investors.
EQRx is a company headquartered in the United States. EQRx has been acquired. Brouky records 2 investors associated with the company.
EQRx was a biopharmaceutical company focused on developing innovative medicines for oncology and immune-inflammatory conditions at radically lower prices. The company aimed to bring ten drugs to market in ten years, focusing on affordable versions of existing therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.